<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03932370</url>
  </required_header>
  <id_info>
    <org_study_id>flexible ureteroscopy</org_study_id>
    <nct_id>NCT03932370</nct_id>
  </id_info>
  <brief_title>Flexible Ureteroscopy Versus Mini-Percutaneous Nephrolithotomy for Treatment of Renal Stones</brief_title>
  <official_title>Flexible Ureteroscopy Versus Mini-Percutaneous Nephrolithotomy for Treatment of Renal Stones 2 Cm or Less; A Randomised, Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Management of nephrolithiasis is evolving rapidly, and various minimally-invasive urological&#xD;
      procedures are currently available for treating patients with renal stones, including&#xD;
      extracorporeal shockwave lithotripsy (ESWL), flexible ureteroscopy (f-URS) and miniaturised&#xD;
      percutaneous nephrolithotomy (mini-PCNL).&#xD;
&#xD;
      Despite being the only truly-non-invasive, outpatient procedure, stone-free rates (SFRs) of&#xD;
      ESWL are lower than both mini-PCNL and f-URS. Furthermore, ESWL has several limitations, such&#xD;
      as pregnancy; uncorrected coagulopathy;aortic aneurism; severe obesity; large stone burdens&#xD;
      (&gt;2cm); stones with high densities (&gt;970/1000 Hounsfield units); ESWL-resistant stone&#xD;
      compositions; lower calyceal stones with unfavourable anatomical criteria; and stones in&#xD;
      calyceal diverticula; Morbidities of the conventional PCNL are significantly minimised by&#xD;
      using less access diameters in PCNL while providing comparable SFRs. Additionally, Mini and&#xD;
      Micro PCNL result in shorter hospital stay and higher tubeless rates compared to conventional&#xD;
      PCNL.&#xD;
&#xD;
      Flexible ureteroscopy has been increasingly used as a primary modality for treatment of renal&#xD;
      stones with significantly lower complication rates than PCNL and mini-PCNL in terms of less&#xD;
      bleeding and transfusion rates, shorter hospital stay and less postoperative pain.&#xD;
      Additionally, f-URS is the only treatment modality of nephrolithiasis that can be safely and&#xD;
      effectively used in patients with bleeding tendency, as well as pregnant women; moreover, its&#xD;
      outcomes are not affected by obesity. Nevertheless, its poor durability and high costs remain&#xD;
      major limitations for f-URS, especially in developing countries.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">May 27, 2019</start_date>
  <completion_date type="Anticipated">May 27, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 27, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>stone clerance</measure>
    <time_frame>postoperative within the first 24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Haemoglobin drop</measure>
    <time_frame>within 24 hours</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Stone;Renal</condition>
  <arm_group>
    <arm_group_label>f-URS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>mini-PCNL</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic surgery</intervention_name>
    <description>The procedure will be performed in an endourology room where a radiolucent operative table together with a C-arm, a video-camera unit and a Laser device are available. Irrigation fluids include normal saline and/or sterile water</description>
    <arm_group_label>f-URS</arm_group_label>
    <arm_group_label>mini-PCNL</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        no specific criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age above than 15 years&#xD;
&#xD;
          2. Renal stone(s) with total burden of 2 cm or less&#xD;
&#xD;
          3. Signature on written, informed consents with the details of this study requirements.&#xD;
&#xD;
          4. Inappropriateness or failure of ESWL (examples of ESWL inappropriateness: patient&#xD;
             preference; distal obstruction; contraindications of ESWL)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1- asymptomatic bacteruria 2- active urinary tract infection (UTI) 3- uncorrected&#xD;
        coagulopathy 4- current use of antiplatelet therapy 5- pregnancy&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 27, 2019</study_first_submitted>
  <study_first_submitted_qc>April 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2019</study_first_posted>
  <last_update_submitted>April 27, 2019</last_update_submitted>
  <last_update_submitted_qc>April 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Amr Esam Saad Mohamed Darwish</investigator_full_name>
    <investigator_title>Dr Amr Darwish</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

